SciCombinator

Discover the most talked about and latest scientific content & concepts.

FM Hammond, DN Alexander, AJ Cutler, S D'Amico, RS Doody, W Sauve, RD Zorowitz, CS Davis, P Shin, F Ledon, C Yonan, AE Formella and J Siffert
Abstract
Phase 3 trials supporting dextromethorphan/quinidine (DM/Q) use as a treatment for pseudobulbar affect (PBA) were conducted in patients with amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). The PRISM II study provides additional DM/Q experience with PBA secondary to dementia, stroke, or traumatic brain injury (TBI).
Tweets*
3
Facebook likes*
0
Reddit*
0
News coverage*
69
Blogs*
0
SC clicks
0
Concepts
Stroke, Excitotoxicity, Minocycline, Dysarthria, Jean-Martin Charcot, Multiple sclerosis, Amyotrophic lateral sclerosis, Traumatic brain injury
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com